Bio‑Rad (BIO) EVP Eva Engelhardt Receives RSU Award; Shares Withheld

What Happened

• Eva Anette Engelhardt, EVP and President, CDG of Bio‑Rad Laboratories (BIO), received restricted stock units (RSUs) and had a portion settle into common shares. A total of 2,179 RSUs converted to 2,179 shares on Sept. 5–6, 2026 (1,027 on 9/5; 1,152 on 9/6). To cover tax liabilities, 854 shares were withheld (369 on 9/5 and 485 on 9/6) at $386.11/share, totaling $329,738. After withholding, Engelhardt received a net 1,325 shares (net value ≈ $511,596 based on $386.11/share). The filing also reports a grant of 4,313 RSUs on Sept. 4, 2026 (the larger RSU award; only 2,179 RSUs were settled in these entries).

Key Details

• Transaction types: A = RSU grant (4,313 RSUs on 2026-09-04); M = conversion/settlement of RSUs to shares (1,027 on 2026-09-05; 1,152 on 2026-09-06); F = shares withheld to satisfy tax withholding (369 and 485 shares).
• Prices and values: withholding price = $386.11/share; withheld shares value = $142,475 (9/5) + $187,263 (9/6) = $329,738. Gross value of settled shares ≈ $841,334; net value after withholding ≈ $511,596.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnotes: RSUs represent contingent rights to receive one share each; vesting schedule described as over four years (25% at first anniversary, remainder in equal quarterly installments). The withholding entries reflect tax-satisfaction, not open-market sales.
• Filing timeliness: Form 4 filed 2026-09-09 reporting transactions from 2026-09-04 to 2026-09-06. No late-filing flag was provided in the supplied data.

Context

• These entries reflect RSU vesting and share settlement with company withholding for taxes (code F), not discretionary open-market selling or buying by the insider. Net issuance to the insider after withholding is typically routine following vesting and does not necessarily indicate a change in the insider’s view of the company.
• For retail investors, purchases are usually stronger signals than vesting/withholding events; this filing documents compensation settlement and tax withholding rather than an insider-initiated buy or sale.